Helio Cure sells FDA-registered Class II medical devices that deliver multi-wavelength red and near-infrared light therapy panels designed to support aging, cognition, skin health, muscle performance, and joint mobility. Each device uses six wavelengths (630, 660, 810, 830, 850, 1064 nm) with deep tissue penetration and offers five precision modes and pre-set programs, available in sizes such as Spark, Glow, Blaze, and Nova for targeted or full-body treatment. The products are backed by human studies and independent lab testing, feature zero blue light and eye safety, and come with a 60-day risk-free trial, a 3-year warranty, HSA/FSA eligibility, and free USA shipping.
AI named Helio Cure in August 2026.
Brand page for heliocure-com